Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by First Horizon Advisors Inc.

First Horizon Advisors Inc. boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 885.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 138 shares of the company’s stock after acquiring an additional 124 shares during the period. First Horizon Advisors Inc.’s holdings in Inspire Medical Systems were worth $26,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. True Wealth Design LLC acquired a new position in Inspire Medical Systems during the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC increased its position in Inspire Medical Systems by 1,158.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after purchasing an additional 139 shares during the period. Nisa Investment Advisors LLC increased its position in Inspire Medical Systems by 37.3% during the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock worth $68,000 after purchasing an additional 100 shares during the period. Quarry LP increased its position in Inspire Medical Systems by 30.9% during the 3rd quarter. Quarry LP now owns 449 shares of the company’s stock worth $95,000 after purchasing an additional 106 shares during the period. Finally, Capital Performance Advisors LLP acquired a new position in Inspire Medical Systems during the 3rd quarter worth approximately $136,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Wells Fargo & Company lowered their price target on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 11th. Stifel Nicolaus lowered their price target on Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a report on Tuesday, January 21st. Morgan Stanley lowered their price target on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating on the stock in a report on Tuesday, February 11th. KeyCorp restated an “overweight” rating and issued a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Inspire Medical Systems presently has an average rating of “Moderate Buy” and an average target price of $228.82.

Inspire Medical Systems Stock Performance

INSP stock opened at $185.56 on Friday. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The stock’s 50 day moving average price is $187.87 and its 200 day moving average price is $193.10. The firm has a market cap of $5.51 billion, a P/E ratio of 107.26, a PEG ratio of 2.86 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insiders Place Their Bets

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now owns 10,424 shares of the company’s stock, valued at $1,777,187.76. This represents a 5.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Randy Ban sold 25,584 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the transaction, the insider now directly owns 7,259 shares in the company, valued at approximately $1,332,026.50. This represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 26,225 shares of company stock valued at $4,806,530 in the last quarter. 4.10% of the stock is currently owned by company insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.